THE IMPACT OF MIGRAINE IN CHILDREN AND ADOLESCENTS ON THE DEVELOPMENT OF MENTAL DISORDERS
Abstract
Objective: Migraine is a common cause of pain in children and adolescents. There has been a consistent rise in the number of diagnoses over the years, which means that the problem is becoming progressively more frequent. The increase in psychiatric diagnoses in children and adolescents, we have raised a question whether there is a connection between these two issues.
Methods: Materials and methods An electronic literature search was performed using PubMed. Search terms included “migraine”, “depression”, “anxiety” “bipolar disease”, “obsesive-compulsive disorder”, “anorexia”, “attention deficit hyperactivity disorder”, “insomnia”, “children”, “adolescents”, “psychiatric disorders” as keywords. The review focused on articles published in English and Polish from their inception until 2025.
Key Findings: Migraine frequently co-occurs with symptoms of anxiety and depression. A higher incidence of bipolar disorder, OCD, and ADHD has been reported in children with migraine. It is possible that migraine and these conditions share common pathophysiologies. Experiencing chronic pain in childhood is also associated with sleep and eating difficulties, reducing the quality of life of paediatric patients.
Conclusion: We present statistics on the co-occurence of these disorders with migraine, as well as reports on the possibility of common pathophysiological substrates and mutual connections, which indicate a significant impact of migraine on the development of mental disorders. However, still more research is needed to obtain valid information on the discovered relationships that would surely help to create more effective and targeted treatment and certainly provide whole-person care for young patients.
References
Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1204-1222. doi:10.1016/S0140-6736(20)30925-9
on behalf of Lifting The Burden: the Global Campaign against Headache, Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137, s10194-020-01208-0. doi:10.1186/s10194-020-01208-0
Battistella P, Fiumana E, Binelli M, et al. Primary Headaches in Preschool Age Children: Clinical Study and Follow-Up in 163 Patients. Cephalalgia. 2006;26(2):162-171. doi:10.1111/j.1468-2982.2005.01008.x
Ferrari AJ, Santomauro DF, Aali A, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403(10440):2133-2161. doi:10.1016/S0140-6736(24)00757-8
Peres MFP, Sacco S, Pozo-Rosich P, et al. Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action. Cephalalgia. 2024;44(8):03331024241267309. doi:10.1177/03331024241267309
Wang Y, Huang X, Yue S, et al. Secular Trends in the Incidence of Migraine in China from 1990 to 2019: A Joinpoint and Age–Period–Cohort Analysis. JPR. 2022;Volume 15:137-146. doi:10.2147/JPR.S337216
Liu Y, Ren Y, Liu C, et al. Global burden of mental disorders in children and adolescents before and during the COVID-19 pandemic: evidence from the Global Burden of Disease Study 2021. Psychol Med. 2025;55:e90. doi:10.1017/S0033291725000649
Mojtabai R, Olfson M. Trends in Mental Disorders in Children and Adolescents Receiving Treatment in the State Mental Health System. Journal of the American Academy of Child & Adolescent Psychiatry. Published online August 2024:S0890856724013571. doi:10.1016/j.jaac.2024.08.008
Gyllenberg D, Bastola K, Wan Mohd Yunus WMA, et al. Comparison of new psychiatric diagnoses among Finnish children and adolescents before and during the COVID-19 pandemic: A nationwide register-based study. Patel V, ed. PLoS Med. 2023;20(2):e1004072. doi:10.1371/journal.pmed.1004072
Falla K, Kuziek J, Mahnaz SR, Noel M, Ronksley PE, Orr SL. Anxiety and Depressive Symptoms and Disorders in Children and Adolescents With Migraine: A Systematic Review and Meta-analysis. JAMA Pediatr. 2022;176(12):1176. doi:10.1001/jamapediatrics.2022.3940
Zhang Q, Shao A, Jiang Z, Tsai H, Liu W. The exploration of mechanisms of comorbidity between migraine and depression. J Cellular Molecular Medi. 2019;23(7):4505-4513. doi:10.1111/jcmm.14390
Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KMA. Comorbidity of migraine and depression: Investigating potential etiology and prognosis. Neurology. 2003;60(8):1308-1312. doi:10.1212/01.WNL.0000058907.41080.54
Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF. Migraine, quality of life, and depression: A population-based case–control study. Neurology. 2000;55(5):629-635. doi:10.1212/WNL.55.5.629
Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KMA. Headache and major depression: Is the association specific to migraine? Neurology. 2000;54(2):308-308. doi:10.1212/WNL.54.2.308
Ligthart L, Hottenga JJ, Lewis CM, et al. Genetic risk score analysis indicates migraine with and without comorbid depression are genetically different disorders. Hum Genet. 2014;133(2):173-186. doi:10.1007/s00439-013-1370-8
Radat F, Swendsen J. Psychiatric Comorbidity in Migraine: A Review. Cephalalgia. 2005;25(3):165-178. doi:10.1111/j.1468-2982.2004.00839.x
Tarantino S, Papetti L, Di Stefano A, et al. Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine. Front Psychol. 2020;11:530911. doi:10.3389/fpsyg.2020.530911
Raudenská J, Macko T, Vodičková Š, Buse DC, Javůrková A. Anxiety Disorders, Anxious Symptomology and Related Behaviors Associated With Migraine: A Narrative Review of Prevalence and Impact. Curr Pain Headache Rep. 2025;29(1):40. doi:10.1007/s11916-024-01312-9
Orr SL, Potter BK, Ma J, Colman I. Migraine and Mental Health in a Population-Based Sample of Adolescents. Can J Neurol Sci. 2017;44(1):44-50. doi:10.1017/cjn.2016.402
Mehrhof SZ, Fiksenbaum LM, Bettridge AM, Goldstein BI. Markedly increased prevalence of migraine headaches in adolescents with bipolar disorder. Bipolar Disorders. 2021;23(3):255-262. doi:10.1111/bdi.12972
Minen MT, Begasse De Dhaem O, Kroon Van Diest A, et al. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry. 2016;87(7):741-749. doi:10.1136/jnnp-2015-312233
Rahman M, Awosika AO, Nguyen H. Valproic Acid. In: StatPearls. StatPearls Publishing; 2025. Accessed June 4, 2025. http://www.ncbi.nlm.nih.gov/books/NBK559112/
O’Connell KS, Coombes BJ. Genetic contributions to bipolar disorder: current status and future directions. Psychol Med. 2021;51(13):2156-2167. doi:10.1017/S0033291721001252
Sharma V, Sharma P, Singh TG. Therapeutic potential of transient receptor potential (TRP) channels in psychiatric disorders. J Neural Transm. 2024;131(9):1025-1037. doi:10.1007/s00702-024-02803-0
De Zambotti M, Goldstone A, Colrain IM, Baker FC. Insomnia disorder in adolescence: Diagnosis, impact, and treatment. Sleep Medicine Reviews. 2018;39:12-24. doi:10.1016/j.smrv.2017.06.009
Bromberg MH, De La Vega R, Law EF, Zhou C, Palermo TM. Development and Validation of the Adolescent Insomnia Questionnaire. Journal of Pediatric Psychology. 2020;45(1):61-71. doi:10.1093/jpepsy/jsz073
Fallah R, Fazelishoroki F, Sekhavat L. A Randomized Clinical Trial Comparing the Efficacy of Melatonin and Amitriptyline in Migraine Prophylaxis of Children. Iran J Child Neurol. 2018;12(1):47-54.
Aydın T, Ayça S, Yurdakul K, Elevli M. Melatonin Levels in Children with Migraine. Neurology India. 2024;72(1):74-77. doi:10.4103/ni.ni_1108_21
Law EF, Ritterband L, Zhou C, Palermo TM. Intervention for Sleep and Pain in Youth (ISPY-RCT): protocol for a two-phase randomized controlled trial of sequenced cognitive-behavioral therapy for insomnia and pain management in adolescents with migraine. Trials. 2023;24(1):25. doi:10.1186/s13063-022-07035-9
Łangowska-Grodzka B, Grodzka O, Czarnecki D, Domitrz I. Is there a correlation between migraine and eating disorders? A systematic literature review. Neurol Neurochir Pol. 2023;57(6):457-464. doi:10.5603/pjnns.97307
Deen M, Christensen CE, Hougaard A, Hansen HD, Knudsen GM, Ashina M. Serotonergic mechanisms in the migraine brain – a systematic review. Cephalalgia. 2017;37(3):251-264. doi:10.1177/0333102416640501
Yokokura M, Terada T, Bunai T, et al. Alterations in serotonin transporter and body image-related cognition in anorexia nervosa. NeuroImage: Clinical. 2019;23:101928. doi:10.1016/j.nicl.2019.101928
Li WW, Zhang JX, Wang J, Chen Y qing, Lai S, Qiu ZK. Bidirectional two-sample Mendelian randomization analysis identifies causal associations between migraine and five psychiatric disorders. Front Neurol. 2024;15:1432966. doi:10.3389/fneur.2024.1432966
Xu G, Strathearn L, Liu B, Yang B, Bao W. Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016. JAMA Netw Open. 2018;1(4):e181471. doi:10.1001/jamanetworkopen.2018.1471
Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis. Pediatrics. 2015;135(4):e994-e1001. doi:10.1542/peds.2014-3482
Arruda MA, Arruda R, Guidetti V, Bigal ME. ADHD Is Comorbid to Migraine in Childhood: A Population-Based Study. J Atten Disord. 2020;24(7):990-1001. doi:10.1177/1087054717710767
Kutuk MO, Tufan AE, Guler G, et al. Migraine and associated comorbidities are three times more frequent in children with ADHD and their mothers. Brain and Development. 2018;40(10):857-864. doi:10.1016/j.braindev.2018.06.001
Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53-63. doi:10.1038/mp.2008.94
Stiede JT, Spencer SD, Onyeka O, et al. Obsessive–Compulsive Disorder in Children and Adolescents. Annual Review of Clinical Psychology. 2024;20(1):355-380. doi:10.1146/annurev-clinpsy-080822-043910
Nazeer A, Latif F, Mondal A, Azeem MW, Greydanus DE. Obsessive-compulsive disorder in children and adolescents: epidemiology, diagnosis and management. Transl Pediatr. 2020;9(S1):S76-S93. doi:10.21037/tp.2019.10.02
Mohammadi MR, Ahmadi N, Hooshyari Z, Khaleghi A, Rismanian Yazdi F, Mehrparvar AH. Prevalence, comorbidity, and predictors of obsessive-compulsive disorder in Iranian children and adolescents. Journal of Psychiatric Research. 2021;141:192-198. doi:10.1016/j.jpsychires.2021.06.018
Vivan ADS, Rodrigues L, Wendt G, Bicca MG, Braga DT, Cordioli AV. Obsessive-compulsive symptoms and obsessive-compulsive disorder in adolescents: a population-based study. Rev Bras Psiquiatr. 2013;36(2):111-118. doi:10.1590/1516-4446-2013-1113
Pavone P, Rizzo R, Conti I, et al. Primary Headaches in Children: Clinical Findings and the Association with other Conditions. Int J Immunopathol Pharmacol. 2012;25(4):1083-1091. doi:10.1177/039463201202500425
Fernández De La Cruz L, Isomura K, Lichtenstein P, Rück C, Mataix-Cols D. Morbidity and mortality in obsessive-compulsive disorder: A narrative review. Neuroscience & Biobehavioral Reviews. 2022;136:104602. doi:10.1016/j.neubiorev.2022.104602
Curone M, Tullo V, Lovati C, Proietti-Cecchini A, D’Amico D. Prevalence and profile of obsessive–compulsive trait in patients with chronic migraine and medication overuse. Neurol Sci. 2014;35(S1):185-187. doi:10.1007/s10072-014-1767-8
Views:
50
Downloads:
16
Copyright (c) 2025 Hanna Nowicka, Emmanuelle Ordon, Maria Joks, Dominika Liszka, Kamila Ostromecka, Paweł Grzesikowski, Kinga Bekier, Jan Krzysztof Górski, Jakub Kubiak, Paulina Klich
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
